Integrum receives reimbursement code for Axor II™
Mölndal, Sweden, September 08, 2023 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that The Centers for Medicare and Medicaid Services (CMS) have granted the osseointegrated external prosthetic connection device Axor II™ a new reimbursement code. The new code, which is expected to take effect in October, is connected to a set reimbursement that will help to drive growth in the US.The new CMS-specific code is granted based on a preliminary benefit category determination that the Axor™ II Ossteointegrated External Prosthetic Connection Device is used in addition